TriSalus Life Sciences Quick Ratio 2021-2024 | TLSI
Historical quick ratio values for TriSalus Life Sciences (TLSI) over the last 10 years.
| TriSalus Life Sciences Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2024-12-31 | $0.02B | $0.01B | 1.63 |
| 2024-09-30 | $0.02B | $0.01B | 2.00 |
| 2024-06-30 | $0.02B | $0.01B | 2.04 |
| 2024-03-31 | $0.01B | $0.01B | 0.71 |
| 2023-12-31 | $0.02B | $0.02B | 1.25 |
| 2023-09-30 | $0.03B | $0.01B | 2.95 |
| 2023-06-30 | $0.00B | $0.01B | 0.00 |
| 2023-03-31 | $0.00B | $0.01B | 0.00 |
| 2022-12-31 | $0.02B | $0.03B | 0.49 |
| 2022-09-30 | $0.00B | $0.00B | 0.00 |
| 2022-06-30 | $0.00B | $0.00B | 0.00 |
| 2022-03-31 | $0.00B | $0.00B | 0.00 |
| 2021-12-31 | $0.00B | $0.00B | 0.00 |
| 2021-09-30 | $0.00B | $0.00B | 0.00 |
| 2021-06-30 | $0.00B | $0.00B | 0.00 |
| 2021-03-31 | $0.00B | $0.00B | 0.00 |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.165B | $0.029B |
| TriSalus Life Sciences Inc. is an oncology company integrating immunotherapy with disruptive delivery technology to transform the treatment paradigm for patients with liver and pancreatic tumors. TriSalus Life Sciences Inc., formerly known as MedTech Acquisition Corporation, is based in CHICAGO. | |||